ICMCI Visits Leverage Consulting, Spotlights China’s Strategy in Execution

ICMCI Visits Leverage Consulting, Spotlights China's Strategy in Execution GlobeNewswire November 03, 2025 SHANGHAI, Nov. 03, 2025 (GLOBE NEWSWIRE) — Amid the worldwide wave of intelligent transformation across industrial chains, the strategic consulting sector is accelerating its integration with the real economy. In recent days, the International Council of Management Consulting Institutes (ICMCI) visited Leverage […]

SINTX Technologies Announces Launch of OsseoSculpt(TM) an Advanced Biologic for Use with SINAPTIC(R) Foot & Ankle Osteotomy Wedge System

SINTX Technologies Announces Launch of OsseoSculpt(TM) an Advanced Biologic for Use with SINAPTIC(R) Foot & Ankle Osteotomy Wedge System GlobeNewswire November 03, 2025 Clinical evaluation of the product by design surgeons completed, driving early commercial momentum SALT LAKE CITY, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”),

Rio2 Announces Receipt of US$50 Million From Wheaton Precious Metals

Rio2 Announces Receipt of US$50 Million From Wheaton Precious Metals GlobeNewswire November 03, 2025 VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2” or “the Company“) (TSX: RIO; OTCQX: RIOFF; BVL: RIO) announces that, further to its news releases dated November 16, 2021, March 29, 2022, October 21, 2024, March 24, 2025,

Dare Bioscience to Receive up to $300,000 to Conduct Global Contraceptive Innovation Capabilities Landscape Assessment

Dare Bioscience to Receive up to $300,000 to Conduct Global Contraceptive Innovation Capabilities Landscape Assessment The project underscores Dare Bioscience's growing role in shaping the future of contraceptive innovation GlobeNewswire November 03, 2025 SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Dare Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing

AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard

AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard Partnership Brings First Mastercard-Approved TON Card Program Enabling Native Cryptocurrency Spending from Digital Wallets with ALT5 Integration GlobeNewswire November 03, 2025 New York, NY, Nov. 03, 2025 (GLOBE NEWSWIRE) — AlphaTON Capital Corp (“AlphaTON Capital” or

Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025

Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025 GlobeNewswire November 03, 2025 RADNOR, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD),

Blaqclouds, Inc. Announces the November 6, 2025 Official Launch of ApolloID — The Web3 Identity Layer of the ZEUS Ecosystem

Blaqclouds, Inc. Announces the November 6, 2025 Official Launch of ApolloID — The Web3 Identity Layer of the ZEUS Ecosystem GlobeNewswire November 03, 2025 ROBESONIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — Blaqclouds, Inc. (OTC: BCDS), a leading innovator in decentralized Web3 infrastructure and blockchain technology, proudly announces that on November 6, 2025, at 5:00

Apollo Funds Complete Acquisition of Stream Data Centers

Apollo Funds Complete Acquisition of Stream Data Centers SDC Positioned to Accelerate Development Across Multi-Gigawatt Hyperscale Pipeline with Apollo Funds' Capital and Strategic Support GlobeNewswire November 03, 2025 NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds (the “Apollo Funds”) have completed the previously announced acquisition of a

Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results

Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results GlobeNewswire November 03, 2025 SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced

Scroll to Top